Pharmaceutical Market Research Insights And Findings
Pharmaceutical Research
Survey of cancer patients finds that the possibility of taking part in clinical trials was not discussed with 43% of respondents
February 2020
Survey of cancer patients finds that clinical trial participation was not discussed with 43% of respondents: A survey has found that the possibility of participating in clinical trials was not discussed with 43% of cancer patients, despite the majority… Read more...
43% female internet users would pay more for sustainable beauty products, reveals global poll
October 2019
43% female internet users would pay more for sustainable beauty products: A global survey of female internet users has revealed that consumers are increasingly seeking sustainable products when it comes to their beauty and cosmetics purchases. The poll… Read more...
8 out of 10 UK pharmacists expect medicine shortages to get worse in the event of no-deal Brexit, reveals survey
October 2019
8 out of 10 UK pharmacists expect medicine shortages to get worse in the event of no-deal Brexit: A survey of UK pharmacists has found that 81% are expecting medicine shortages are to get worse if the UK crashes out of the EU on October 31 without a… Read more...
Number of UK patient groups saying pharma has 'good' or 'excellent' reputation has fallen, according to survey
October 2019
Number of UK patient groups saying pharma has 'good' or 'excellent' reputation has fallen: A survey of patient groups across 50 specialities in the UK, has found a decrease in the number of patient groups awarding pharma companies a 'good'… Read more...
Brits confused about CBD and its effects, according to recent poll
October 2019
Brits confused about CBD and its effects: A survey asking more than 2,000 UK adults about their thoughts and opinions around cannabidiol (CBD) has found that there is some confusion about its effects - with some believing it to be addictive or to have psychoactive… Read more...
Just 9% of patient groups rate pharma industry positively in terms of fair pricing policies, according to report
May 2019
Just 9% of patient groups rate pharma industry positively in terms of fair pricing policies: An annual report based on findings of a PatientView corporate reputation survey found that less than one in ten patient groups rated pharma companies as ‘excellent’… Read more...
